HCPCS Code C9092

Injection, triamcinolone acetonide, suprachoroidal (xipere), 1 mg
Code effective Jul 01, 2022

HCPCS Section
Temporary Codes for Use with Outpatient Prospective Payment System

C9092 is a valid 2026 HCPCS code meaning Injection, triamcinolone acetonide, suprachoroidal (xipere), 1 mg or (Inj., xipere, 1 mg) for short. HCPCS C9092 has been effective since 07/01/2022 and applies to Other medical items or services.

HCPCS Code Details - C9092

HCPCS Level II Code
Section C - Temporary Codes for Use with Outpatient Prospective Payment System
HCPCS Code C9092
Description

Long description:
Injection, triamcinolone acetonide, suprachoroidal (xipere), 1 mg

Short description:
Inj., xipere, 1 mg

HCPCS Pricing indicator 53 - Statute
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Statute number 1833(t)
Coverage code D - Special coverage instructions apply
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service 9 - Other medical items or services
Effective date Effective Jul 01, 2022
Date added Added Apr 01, 2022
Termination date Jun 30, 2022

See also

  • HCPCS C9091 · Injection, sirolimus protein-bound particles, 1 mg

  • HCPCS C9469 · Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg

  • HCPCS J3300 · Injection, triamcinolone acetonide, preservative free, 1 mg

  • HCPCS J3301 · Injection, triamcinolone acetonide, not otherwise specified, 10 mg

  • HCPCS J3304 · Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg

  • HCPCS Q9993 · Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg

  • HCPCS C9093 · Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.